News & Insights
Professionals
Focus Areas
Regions
Type
Sort By
Client News 1 result
Client News
|November 6, 2025
Gunderson Dettmer represented long-time client BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company on a mission to make powerful and accessible genetic tests available to all, in its initial public offering of 4.6 million shares of Class A common stock at a price to the public of $60 per share, generating approximately $273.1 billion in aggregate gross proceeds.